Fig. 2
From: SETD2 mutations in primary central nervous system tumors
Location of mutations within SETD2 and co-occurring pathogenic mutations. a Schematic representation of the locations of mutations in SETD2 for the 16 cases presented in the current study (i) and the TCGA database (ii) (AWS, Associated with SET). b Other pathogenic mutations co-occurring in tumors with SETD2 mutations with the percentage of tumors with each mutation is labeled within each cell. Darker shading corresponds to higher percentages. Truncating mutations (TM), missense mutation (MM)